Home
Applications
Indications
Business
EpiSwitch
®
Products
EpiSwitch
®
Explorer Kit
EpiSwitch
®
Service
Investors
Investors Overview
Results and Presentations
Share Price Information
Regulatory News
Board & Governance
Key Corporate Documents
AIM Rule 26
Email Alerts
Investor Contacts
News
About Us
History
Board of Directors
Management Team
Scientific Advisory Panel
Values
Careers
OBD is expanding its biomarker discovery programme for the development of companion diagnostic tests for Amyotrophic Lateral Sclerosis (ALS), using its EpiSwitch™ technology.
January 28, 2016
|
In
Milestones
|
By
Catia Gaspar
EPM Magazine Press Release
Prev
Next
Privacy Preference Center
Privacy Preferences